Jane Street’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,900
Closed -$275K 10721
2025
Q1
$275K Sell
10,900
-28,100
-72% -$835K ﹤0.01% 7948
2024
Q4
$1.34M Sell
39,000
-56,100
-59% -$2.53M ﹤0.01% 4855
2024
Q3
$4.7M Buy
95,100
+84,400
+789% +$4.32M ﹤0.01% 2963
2024
Q2
$644K Sell
10,700
-12,100
-53% -$691K ﹤0.01% 6607
2024
Q1
$1.18M Buy
22,800
+7,800
+52% +$383K ﹤0.01% 5107
2023
Q4
$605K Sell
15,000
-14,300
-49% -$419K ﹤0.01% 6441
2023
Q3
$817K Buy
+29,300
New +$874K ﹤0.01% 5495

Other funds holding RXST

Jane Street's RXST Position: Q1 2026 in Review

Jane Street reduced its RxSight (RXST) stake by 5.9% in Q1 2026, selling an estimated $117K and leaving 223,904 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #5804.

Jane Street first reported a position in RXST in Q1 2023 and has held it in 12 quarters since. The position peaked at $3.11M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Jane Street held 223,904 shares of RxSight worth $1.38M as of Q1 2026.
  • Jane Street sold 14,067 RxSight shares in Q1 2026, an estimated $117K.
  • RxSight made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5804 holding.
  • Jane Street first reported a position in RxSight in Q1 2023 and has held it in 12 quarters since.
  • Jane Street's RxSight position peaked at $3.11M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.